Eli Lilly Stock: Buy or Sell? - Nasdaq

With the market favoring the stock now, Eli Lilly is trading close to its mean target price of $633.50, which is just 2.5% overhead. Its high target price of $727, however, indicates a 14.8% ...

5%
OFF

Eli Lilly Stock: Buy Or Sell? - Nasdaq

2 weeks from now

With the market favoring the stock now, Eli Lilly is trading close to its mean target price of $633.50, which is just 2.5% overhead. Its high target price of $727, however, indicates a 14.8% ...

nasdaq.com

10%
OFF

Eli Lilly Falls More Than 10% In A Month: Buy, Sell Or Hold

2 weeks from now

Nov 11, 2024 · Lilly’s stock has risen 42.7% so far this year compared with an increase of 11.6% for the industry. The stock has also outperformed the sector as well as the S&P 500, as seen …

nasdaq.com

20%
OFF

Down More Than 20% From Its High, Is Now The Time To Buy Eli …

2 weeks from now

Nov 28, 2024 · Eli Lilly (LLY 1.61%) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion. But in recent weeks, its share price has been …

fool.com

3%
OFF

LLY, ABT, Or ISRG: Which "Strong Buy" Healthcare Stock Could

2 weeks from now

6 days ago · Overall, Wall Street has a Strong Buy consensus rating on Eli Lilly stock based on 15 Buys and two Hold ratings. The average LLY stock price target of $1,050.79 implies 37.3% …

nasdaq.com

3%
OFF

Eli Lilly (LLY) Stock Declines While Market Improves: Some …

2 weeks from now

1 day ago · Eli Lilly (LLY Quick Quote LLY - Free Report) ended the recent trading session at $797.48, demonstrating a -0.3% swing from the preceding day's closing price. The stock fell …

zacks.com

55%
OFF

Is Eli Lilly Stock A Buy? - Nasdaq

2 weeks from now

Oct 30, 2024 · Powered by its popular GLP-1 weight loss drugs, Eli Lilly's stock (NYSE: LLY) has had a strong run this year, up more than 55%. However, the company's success goes back …

nasdaq.com

3%
OFF

Eli Lilly (LLY) Stock Declines While Market Improves: Some

2 weeks from now

12 hours ago · Eli Lilly (LLY) ended the recent trading session at $797.48, demonstrating a -0.3% swing from the preceding day's closing price. The stock fell short of the S&P 500, which …

nasdaq.com

FAQs about Eli Lilly Stock: Buy or Sell? - Nasdaq Coupon?

Is Eli Lilly (LLY) a good stock to buy?

Solid growth prospects, however, could propel the business a lot higher. Eli Lilly (LLY 0.91%) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion. But in recent weeks, its share price has been falling. And now the stock is down over 20% from its 52-week high of $972.53. ...

Is Eli Lilly & Co stock undervalued?

Current stock price is around $803.38, which may be perceived as undervalued given the company's growth prospects and recent analyst target prices ranging from $885.00 to $1,100.00. Investors should be bearish about investing in Eli Lilly and Co for these reasons: ...

Is Eli Lilly a dividend-paying stock?

Another green flag is that Eli Lilly is a dividend-paying stock. While its yield is low at 0.84%, compared to the sector average of 1.58%, the company has paid dividends consistently for the past 34 years. It has also increased its dividends for the past 10 years in a row. ...

Should you buy Eli Lilly & Co (ell)?

The company has a strong consensus rating of "Moderate Buy" from analysts, indicating positive sentiment and potential for stock appreciation. Eli Lilly and Co recently announced a quarterly dividend increase to $1.50, reflecting a commitment to returning value to shareholders. ...

Is Eli Lilly a good healthcare stock to buy?

Eli Lilly is one of the top healthcare stocks you can own for the long haul, and now can be an optimal time to add it to your portfolio. David Jagielski has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. ...

Why has Eli Lilly stock rallied 30% this year?

Eli Lilly’s LLY stock has rallied 30% this year due to optimism about two potential new product lines. The key drivers of the rally in Eli Lilly stock are the potential for two of the company’s drugs: Mounjaro (tirzepatide) for weight loss and donanemab for early Alzheimer’s. ...